We are now Acumetis
Herspiegel Acquires Decisive Consulting to Expand Global Life Sciences Commercialization Services
Blending Bold Strategy with Proven Market Access and Health Economics Expertise to Unlock Asset Value
YARDLEY, PA and LONDON, UK – June 23, 2025 – Herspiegel, a leader in pharmaceutical commercialization services, today announced the acquisition of Decisive Consulting. This strategic expansion unites Decisive’s global market access focused “Rebel Thinking” with Herspiegel's world-class commercialization services, creating a powerhouse of strategy, evidence, and execution across the product lifecycle.
Latest insights
Breakthrough access results, even in challenging circumstances
-

Enabling Better Decisions
We enable our clients to plan for what matters most making sure promising technologies and treatments reach those they are designed to support.
-

Our Services
We are ready to walk with our clients in implementing plans and programs as well as developing the core strategies that drive them.
-

View insights
We have the experience of senior industry professionals that provide razor-sharp insights to help you move swiftly from plans to actions.
It’s not just what we do, it’s how we do it…
A Rebel approach to every decisive moment
Make it stand out